V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10455746 | 10034564 | 1.8 | 88.4 | Palliative (P) | 2017-04-14 | 2017-04-14 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101122124 |
| 10455747 | 10034565 | 0 | 45.4 | Curative (C) | 2017-08-08 | 2017-08-09 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | PEMBROLIZUMAB | 100611528 |
| 10455756 | 10034566 | 1.73 | null | 03 | 2018-12-03 | 2018-12-03 | IBRUTINIB | 02 | N | IBRUTINIB | 100495396 |
| 10455777 | 10034567 | 1.82 | 77.6 | Disease modification (D) | 2019-03-02 | 2019-03-23 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101379796 |
| 10455782 | 10034568 | 1.65 | 50.6 | Palliative (P) | 2017-09-17 | 2017-09-17 | Docetaxel | 02 | N | DOCETAXEL | 100717888 |
| 10455798 | 10034569 | 1.56 | 74.8 | Adjuvant (A) | 2018-05-23 | 2018-06-17 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 100314750 |
| 10455805 | 10034570 | null | 73.4 | Palliative (P) | 2014-10-27 | 2014-10-29 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101651154 |
| 10455812 | 10034571 | 1.69 | 64 | null | 2019-12-18 | 2019-12-27 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 100293219 |
| 10455831 | 10034572 | 1.61 | 53 | Curative (C) | 2019-02-20 | 2019-03-21 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101459180 |
| 10455844 | 10034573 | 1.52 | 105.75 | null | 2022-01-05 | 2022-01-17 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101252510 |
| 10455859 | 10034574 | 1.64 | 95.9 | Curative (C) | 2016-12-26 | 2017-01-06 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100764282 |
| 10455876 | 10034575 | 1.75 | 90 | Curative (C) | 2019-03-16 | 2019-03-30 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101197254 |
| 10455879 | 10034576 | 1.74 | 77.2 | Palliative (P) | 2021-01-08 | 2021-01-15 | Capecitabine + Oxaliplatin 14day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100241723 |
| 10455881 | 10034577 | 1.72 | 97.4 | Adjuvant (A) | 2017-01-04 | 2017-01-07 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100877556 |
| 10455929 | 10034578 | 1.65 | 83.1 | Curative (C) | 2017-08-23 | 2017-09-11 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101175328 |
| 10455960 | 10034579 | 1.64 | 52.8 | Curative (C) | 2021-06-18 | 2021-06-20 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101806430 |
| 10455963 | 10034580 | 1.76 | 53.7 | Palliative (P) | 2019-04-23 | 2019-04-30 | Capecitabine + Oxaliplatin 21day | 2 | N | CAPECITABINE + OXALIPLATIN | 100160835 |
| 10455976 | 10034581 | 0 | 60.4 | null | 2020-05-22 | 2020-05-22 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100254779 |
| 10455980 | 10034582 | null | 118.2 | 03 | 2021-05-07 | 2021-05-14 | Rituximab | 02 | null | RITUXIMAB | 100341004 |
| 10456060 | 10034583 | 1.77 | 91 | Palliative (P) | 2017-11-02 | 2017-11-07 | PEMBROLIZUMAB | 02 | N | DOCETAXEL | 100368824 |
| 10456068 | 10034584 | 1.82 | 89.2 | null | 2021-02-24 | 2021-03-08 | Capecitabine + Oxaliplatin 21day | 02 | null | PEMBROLIZUMAB | 101528237 |
| 10456081 | 10034585 | 0 | 68.5 | Curative (C) | 2019-08-30 | 2019-09-08 | CAPECITABINE + OXALIPLATIN | 2 | N | PEMBROLIZUMAB | 101540615 |
| 10456105 | 10034586 | 1.73 | 69.3 | Curative (C) | 2017-12-21 | 2017-12-27 | Rituximab | 02 | null | RITUXIMAB | 101183319 |
| 10456122 | 10034587 | 1.52 | 76.2 | Adjuvant (A) | 2017-02-15 | 2017-02-15 | CAPECITABINE + OXALIPLATIN | 01 | N | IBRUTINIB | 100163234 |
| 10456130 | 10034588 | 1.62 | 76.3 | Palliative (P) | 2021-06-17 | 2021-06-17 | CAPECITABINE + OXALIPLATIN | 02 | N | RITUXIMAB | 100338502 |
| 10456132 | 10034589 | 1.6 | 116.6 | 03 | 2019-10-24 | 2019-10-27 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101517897 |
| 10456137 | 10034590 | 1.79 | 84 | Adjuvant (A) | null | 2016-12-26 | Docetaxel | 02 | N | DOCETAXEL | 100906101 |
| 10456150 | 10034591 | 1.58 | 73.35 | null | 2022-04-30 | 2022-04-30 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101170925 |
| 10456151 | 10034592 | 1.65 | 55.3 | null | 2021-11-29 | 2021-12-05 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101638535 |
| 10456177 | 10034593 | 1.73 | 71.7 | null | 2020-06-01 | 2020-06-09 | CAPECITABINE + OXALIPLATIN | 02 | null | IBRUTINIB | 101035408 |
| 10456183 | 10034594 | 1.78 | 68 | Adjuvant (A) | 2020-02-03 | 2020-02-03 | IBRUTINIB | null | null | IBRUTINIB | 100535965 |
| 10456193 | 10034595 | 1.66 | 45 | Palliative (P) | 2016-01-29 | 2016-02-05 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 101689730 |
| 10456207 | 10034596 | 1.57 | 70.3 | null | 2016-04-17 | 2016-04-25 | IBRUTINIB | 02 | null | IBRUTINIB | 100878808 |
| 10456224 | 10034597 | 1.67 | 101 | Palliative (P) | 2016-12-28 | 2017-01-12 | Docetaxel | 02 | null | DOCETAXEL | 101246934 |
| 10456225 | 10034598 | 1.8 | 66.3 | Curative (C) | 2016-09-25 | 2016-09-25 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100794530 |
| 10456241 | 10034599 | 1.79 | 94 | 03 | 2017-02-12 | 2017-02-15 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101216782 |
| 10456243 | 10034600 | 1.74 | 73.6 | Palliative (P) | 2017-11-19 | 2017-12-25 | Rituximab | 02 | null | RITUXIMAB | 100235160 |
| 10456250 | 10034601 | 1.65 | 66 | Palliative (P) | 2017-04-16 | 2017-05-04 | Capecitabine + Oxaliplatin 21day | 02 | N | IBRUTINIB | 100033587 |
| 10456265 | 10034602 | 1.59 | 75.3 | Palliative (P) | 2016-12-28 | 2017-01-24 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101137099 |
| 10456281 | 10034603 | 1.59 | 45.95 | Palliative (P) | 2018-04-04 | 2018-04-06 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 100675180 |
| 10456288 | 10034604 | 1.61 | 88.85 | Palliative (P) | 2019-08-02 | 2019-08-14 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 101348983 |
| 10456290 | 10034605 | null | 50 | null | 2021-11-06 | 2021-12-04 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101720916 |
| 10456295 | 10034606 | 1.73 | 75.5 | Adjuvant (A) | 2020-02-09 | 2020-02-23 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 100843612 |
| 10456297 | 10034607 | 1.66 | 38.6 | Adjuvant (A) | 2019-05-18 | 2019-06-15 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 101074340 |
| 10456332 | 10034608 | 1.71 | 49.3 | null | 2017-09-02 | 2017-09-02 | Rituximab | 02 | null | RITUXIMAB | 100270589 |
| 10456335 | 10034609 | 1.61 | 87.6 | Palliative (P) | 2020-07-22 | 2020-08-17 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100970731 |
| 10456337 | 10034610 | 1.67 | 65 | Curative (C) | 2018-11-21 | 2018-11-22 | Rituximab | 02 | N | RITUXIMAB | 100513193 |
| 10456344 | 10034611 | 1.63 | 74.3 | Disease modification (D) | 2016-05-01 | 2016-05-12 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101512398 |
| 10456347 | 10034612 | 1.55 | 76.65 | 03 | 2021-02-13 | 2021-02-26 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101460335 |
| 10456371 | 10034613 | 1.65 | 85 | 03 | 2019-06-19 | 2019-06-29 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101814597 |